Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in Mainland China: A multicenter cross-sectional study

Nephrology

Volumn 18, Issue 4, 2013, Pages 307-312

  Cao, Ying ^a   Gong, Mengchun ^a   Han, Yang ^a   Xie, Jing ^a   Li, Xuemei ^a   Zhang, Lixia ^a   Li, Yanling ^a   Song, Xiaojing ^a   Zhu, Ting ^a   Li, Taisheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

chronic renal disease; human immunodeficiency virus; prevalence; proteinuria; risk factor

Indexed keywords

CREATININE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CHINA; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS B VIRUS; HEPATITIS C; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; VIRUS LOAD;

ADULT; CHI-SQUARE DISTRIBUTION; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROTEINURIA; REAGENT STRIPS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; URINALYSIS; VIRAL LOAD;

EID: 84875720421     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12031     Document Type: Article

References (30)

1. World Health Organization. 2009 Estimates for the HIV/AIDS Epidemic in China. Beijing: Ministry of Health of the People's Republic of China, Joint United Nations Programme on HIV/AIDS, 2010. [Cited 31 May 2010.] Available from URL: http://www.unaids.org.cn/download/2009%20China%20Estimation%20Report-En.pdf
2. Selik RM, Byers RH Jr, Dworkin MS,. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J. Acquir. Immune Defic. Syndr. 2002; 29: 378-387.
3. Schwartz EJ, Szczech LA, Ross MJ, et al. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J. Am. Soc. Nephrol. 2005; 16: 2412-2420.
4. Naicker S, Fabian J,. Risk factors for the development of chronic kidney disease with HIV/AIDS. Clin. Nephrol. 2010; 74: 51-56.
5. Gardner LI, Holmberg SD, Williamson JM, et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J. Acquir. Immune Defic. Syndr. 2003; 32: 203-209.
6. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine association of the infectious diseases society of America. Clin. Infect. Dis. 2009; 49: 651-681.
7. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130: 461-470.
8. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, & stratification. Am. J. Kidney Dis. 2002; 39: S1-266.
9. Cheung CY, Wong KM, Lee MP, et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol. Dial. Transplant. 2007; 22: 3186-3190.
10. Zhang LX, Zhang PH, Wang F, et al. Prevalence and factors associated with CKD: A population study from Beijing. Am. J. Kidney Dis. 2008; 51: 373-384.
11. Liu D, Liui Z, Hu X, et al. Epidemiology investigation on chronic kidney disease among adults in urban communities of Zhengzhou city. Chin. J. Nephrol. 2008; 24: 603-607.
12. Chen W, Wang H, Dong X, et al. Guangzhou City in the general population epidemiological studies of chronic kidney disease. Chin. J. Nephrol. 2007; 23: 147-151.
13. Guo L, Zhang L, Wang X, et al. Zhejiang Province, a rural epidemiological studies of chronic kidney disease. Chin. J. Nephrol. 2007; 23: 152-156.
14. Estrella MM, Fine DM,. Screening for chronic kidney disease in HIV-infected patients. Adv. Chronic Kidney Dis. 2010; 17: 26-35.
15. Gaspari F, Perico N, Remuzz G,. Measurement of glomerular filtration rate. Kidney Int. Suppl. 1997; 63: S151-154.
16. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann. Intern. Med. 2003; 139: 137-147.
17. Levey AS,. Measurement of renal function in chronic renal disease (clinical conference). Kidney Int. 1990; 38: 167-184.
18. Verhave JC, Fesler P, Ribstein J, et al. Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index. Am. J. Kidney Dis. 2005; 46: 233-241.
19. Cockcroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
20. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin. Infect. Dis. 2005; 40: 1559-1585.
21. Wyatt CM, Winston JA, Malvestutto CD, et al. Chronic kidney disease in HIV infection: An urban epidemic. AIDS 2007; 21: 2101-2103.
22. Sorli ML, Guelar A, Montero M, et al. Chronic kidney disease prevalence and risk factors among HIV-infected patients. J. Acquir. Immune Defic. Syndr. 2008; 48: 506-508.
23. Biagio AD, Rosso R, Vitale F, et al. Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. Clin. Nephrol. 2011; 75: 518-523.
24. Wyatt CM, Malvestutto C, Coca SG, et al. The impact of hepatitis C virus coinfection on HIV-related kidney disease: A systematic review and meta-analysis. AIDS 2008; 22: 1799-1807.
25. Izzedinea H, Seneb D, Cacoub P, et al. Kidney diseases in HIV/HCV-co-infected patients. AIDS 2009; 23: 1219-1226.
26. Szczech LA, Gange SJ, van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002; 61: 195-202.
27. Winston JA,. HIV and CKD Epidemiology. Adv. Chronic Kidney Dis. 2010; 17: 19-25.
28. Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol. Dial. Transplant. 2006; 21: 2809-2813.
29. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N. Engl. J. Med. 2006; 355: 2283-2296.
30. Shlipak MG,. Cystatin C: Research priorities targeted to clinical decision making. Am. J. Kidney Dis. 2008; 51: 358-361.